Levamisole seems to regulate cell-mediated immunity by restoring T-cell function. Since a deficiency of T lymphocytes has been described by various authors in multiple sclerosis patients. Of the 85 patients involved in the trial, evaluation of functional and neurological scores was possible in 54 (3
β¦ LIBER β¦
Four year double-blind controlled study of levamisole in multiple sclerosis
β Scribed by A. R. Massaro; R. P. Cioffi; A. Laudisio; D. Schiavino; M. Mariani
- Publisher
- Springer Milan
- Year
- 1990
- Tongue
- English
- Weight
- 468 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Modulation of immunity in multiple scler
β
R. E. Gonsette; L. Demonty; P. Delmotte; J. Decree; W. de Cock; H. Verhaeghen; J
π
Article
π
1982
π
Springer
π
English
β 443 KB
Double blind controlled randomized study
β
C. Milanese; L. La Mantia; A. Salmaggi; A. Campi; C. Bortolami; L. Tajoli; A. Ne
π
Article
π
1988
π
Springer Milan
π
English
β 401 KB
Double-blind placebo controlled crossove
β
Bruce Miller; Paula De Merieux; Ramachandran Srinivasan; Philip Clements; Peng F
π
Article
π
1980
π
John Wiley and Sons
π
English
β 870 KB
A double blind study on azathioprine eff
β
C. Milanese; L. Mantia; A. Salmaggi; M. Eoli
π
Article
π
1993
π
Springer
π
English
β 352 KB
Azathioprine in multiple sclerosisβA 3 y
β
U. Patzold; P. Pocklington
π
Article
π
1980
π
Springer
π
English
β 895 KB
The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected
A three-year double-blind placebo-contro
β
A N Taquet; B. Clemmensen; B. Zegels; P. Ravin; C. Christiansen; I. Roumagnac; J
π
Article
π
1996
π
Springer-Verlag
π
English
β 152 KB